Related Experiment Video
Updated: Sep 13, 2026

Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis
Published on: January 16, 2013
[Bacterial prostatitis--therapeutic principles]
Abstract:
The authors examined the possibilities of the treatment of bacterial prostatitis and yielded the following result: A medicament suited for the treatment of prostatitis must fulfil such chemical criteria, as they are at present to be found only in alkaline marcolids (e.g. erythromycin) and trimethoprim. Since trimehtoprim has a good spectre of action against gram-negative germs, it seems to be the suited remedy, for these pathogens are frequent and dominating in the pathogenesis of prostatitis. Gram-positive bacteria should be accessible to a therapy with erythromycin.
Insights
For bacterial prostatitis treatment, alkaline macrolides like erythromycin and trimethoprim are effective. Trimethoprim targets gram-negative bacteria, while erythromycin addresses gram-positive pathogens.
Area of Science:
- Microbiology
- Pharmacology
- Urology
Context:
- Bacterial prostatitis is a common infection requiring effective antimicrobial treatment.
- Identifying suitable antimicrobial agents is crucial for successful treatment outcomes.
- Current treatment options may face challenges with specific bacterial pathogens.
Purpose:
- To evaluate the chemical properties of potential prostatitis treatment medications.
- To determine the efficacy of specific antimicrobial classes against common prostatitis pathogens.
- To identify optimal therapeutic agents for bacterial prostatitis.
Summary:
- Alkaline macrolides (e.g., erythromycin) and trimethoprim possess chemical criteria suitable for prostatitis treatment.
- Trimethoprim demonstrates broad-spectrum activity against gram-negative bacteria, prevalent in prostatitis pathogenesis.
- Erythromycin is effective against gram-positive bacteria, which can also cause prostatitis.
Impact:
- This research aids in selecting appropriate antibiotics for bacterial prostatitis.
- It provides a basis for developing more targeted prostatitis therapies.
- Understanding pathogen-specific efficacy can improve patient treatment and recovery.
Related Concept Videos
Urinary Tract Infection II: Pathophysiology
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Infection IV: Nursing Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Microbiota of the Urogenital Tract
Determinants of Bacterial Pathogenicity and Virulence

